Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bayer animal health gmbh - cyanocobalamine; butafosfan - oplossing voor injectie - cyanocobalamine 50 µg/ml; butafosfan 100 mg/ml, - tonics - honden; katten; pelsdieren; runderen

Nederland - Nederlands - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

bayer animal health gmbh - cyanocobalamine; butafosfan - oplossing voor injectie - cyanocobalamine 0,05 mg/ml; butafosfan 100 mg/ml, - tonics - honden; kalveren; katten; pelsdieren; runderen

België - Nederlands - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bayer animal health - cyanocobalamine; a-butyl amino isopropyl fosfonzuur - oplossing voor injectie - 100 mg/ml - 0,05 mg/ml - cyanocobalamine 0.05 mg/ml; a-butyl amino isopropyl fosfonzuur 100 mg/ml - butafosfan - rund; hond; kat; andere of onbekend

Europese Unie - Nederlands - EMA (European Medicines Agency)

mylan ireland limited - fingolimod hydrochloride - multiple sclerose, relapsing-remitting - immunosuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 en 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.